147 related articles for article (PubMed ID: 23409951)
41. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
[TBL] [Abstract][Full Text] [Related]
42. Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy.
ElKhatib MAW; Isse FA; El-Kadi AOS
Drug Metab Rev; 2023; 55(1-2):50-74. PubMed ID: 36573379
[TBL] [Abstract][Full Text] [Related]
43. Low-level m-Xylene inhalation alters pulmonary and hepatic cytochrome P-450 activity in the rat.
Foy JW; Silverman DM; Schatz RA
J Toxicol Environ Health; 1996 Feb; 47(2):135-44. PubMed ID: 8598570
[TBL] [Abstract][Full Text] [Related]
44. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
[TBL] [Abstract][Full Text] [Related]
45. Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase.
Labitzke EM; Diani-Moore S; Rifkind AB
Arch Biochem Biophys; 2007 Dec; 468(1):70-81. PubMed ID: 17959137
[TBL] [Abstract][Full Text] [Related]
46. Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding.
Iba MM; Fung J; Pak YW; Thomas PE; Fisher H; Sekowski A; Halladay AK; Wagner GC
Drug Metab Dispos; 1999 Sep; 27(9):977-82. PubMed ID: 10460794
[TBL] [Abstract][Full Text] [Related]
47. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice.
Deng Y; Edin ML; Theken KN; Schuck RN; Flake GP; Kannon MA; DeGraff LM; Lih FB; Foley J; Bradbury JA; Graves JP; Tomer KB; Falck JR; Zeldin DC; Lee CR
FASEB J; 2011 Feb; 25(2):703-13. PubMed ID: 21059750
[TBL] [Abstract][Full Text] [Related]
48. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
Cizkova K; Tauber Z
Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
[TBL] [Abstract][Full Text] [Related]
49. Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats.
Zhao X; Dey A; Romanko OP; Stepp DW; Wang MH; Zhou Y; Jin L; Pollock JS; Webb RC; Imig JD
Am J Physiol Regul Integr Comp Physiol; 2005 Jan; 288(1):R188-96. PubMed ID: 15345471
[TBL] [Abstract][Full Text] [Related]
50. Epoxyeicosatrienoic acid pathway in human health and diseases.
Bellien J; Joannides R
J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
[TBL] [Abstract][Full Text] [Related]
51. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
[TBL] [Abstract][Full Text] [Related]
52. Identification of rabbit cytochromes P450 2C1 and 2C2 as arachidonic acid epoxygenases.
Laethem RM; Koop DR
Mol Pharmacol; 1992 Dec; 42(6):958-63. PubMed ID: 1480136
[TBL] [Abstract][Full Text] [Related]
53. Soluble Epoxide Hydrolase as a Potential Key Factor for Human Prenatal Development.
Cizkova K; Rajdova A; Ehrmann J
Cells Tissues Organs; 2016; 201(4):277-86. PubMed ID: 27144772
[TBL] [Abstract][Full Text] [Related]
54. Modulation of cardiac cytochrome P450 in patients with heart failure.
Aspromonte N; Monitillo F; Puzzovivo A; Valle R; Caldarola P; Iacoviello M
Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):327-39. PubMed ID: 24387291
[TBL] [Abstract][Full Text] [Related]
55. Change in soluble epoxide hydrolase (sEH) during cisplatin-induced acute renal failure in mice.
Hashimoto T; Fang YI; Ohata H; Honda K
J Toxicol Sci; 2015 Aug; 40(4):451-7. PubMed ID: 26165641
[TBL] [Abstract][Full Text] [Related]
56. Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.
Luria A; Weldon SM; Kabcenell AK; Ingraham RH; Matera D; Jiang H; Gill R; Morisseau C; Newman JW; Hammock BD
J Biol Chem; 2007 Feb; 282(5):2891-8. PubMed ID: 17135253
[TBL] [Abstract][Full Text] [Related]
57. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.
Holla VR; Adas F; Imig JD; Zhao X; Price E; Olsen N; Kovacs WJ; Magnuson MA; Keeney DS; Breyer MD; Falck JR; Waterman MR; Capdevila JH
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5211-6. PubMed ID: 11320253
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis.
Wells MA; Vendrov KC; Edin ML; Ferslew BC; Zha W; Nguyen BK; Church RJ; Lih FB; DeGraff LM; Brouwer KL; Barritt AS; Zeldin DC; Lee CR
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():19-29. PubMed ID: 27401401
[TBL] [Abstract][Full Text] [Related]
59. The Antihypertensive Effect of Quercetin in Young Spontaneously Hypertensive Rats; Role of Arachidonic Acid Metabolism.
Elbarbry F; Abdelkawy K; Moshirian N; Abdel-Megied AM
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911626
[TBL] [Abstract][Full Text] [Related]
60. 5,6-δ-DHTL, a stable metabolite of arachidonic acid, is a potential substrate for paraoxonase 1.
Eryanni-Levin S; Khatib S; Levy-Rosenzvig R; Tamir S; Szuchman-Sapir A
Biochim Biophys Acta; 2015 Sep; 1851(9):1118-22. PubMed ID: 25958017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
